Biotech · Private company · Princeton, NJ, US
Enalare Therapeutics Inc.
Track this companyFree. Adds Enalare Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- ENA-001Phase 1 · Respiratory DepressionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- ENA-001 for Opioid Induced Respiratory DepressionPHASE1 · COMPLETED · started May 14, 2025ClinicalTrials.gov NCT06967259 · fetched Nov 12, 2026
NIH awards1
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.Fiscal year 2025 · $2.5MNIH RePORTER 4R44DA057133-02 · fetched Nov 12, 2026